Pathology EMQ template.

Name: Sukriti Sinha

Theme: Respiratory disease

OPTION LIST

A	K-ras	I
B	Small cell carcinoma	J
C	Large cell carcinoma	K
D	EGFR	L
E	Squamous cell carcinoma	M
F	ERCC1	N
G	Adenocarcinoma	O
H	EML4-ALK1	P

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

1. TKIs such as Erlotinib, may be useful against this mutation.

2. This mutation renders the tumour resistant to cisplatin.

3. No glandular or squamous differentiation on histological analysis, but squamous differentiation seen on electron microscopy.

4. Malignant cells can show signs of keratinisation.

5. Some patients with this type of tumour can develop fatal haemorrhage if taking bevacizumab.

ANSWERS

1. D

2. F

3. C

4. E

5.E